Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Impact of Gentamicin Concentration and Exposure Time on Intracellular Yersinia pestis.

VanCleave TT, Pulsifer AR, Connor MG, Warawa JM, Lawrenz MB.

Front Cell Infect Microbiol. 2017 Dec 11;7:505. doi: 10.3389/fcimb.2017.00505. eCollection 2017.

2.

Validation of 2-18F-Fluorodeoxysorbitol as a Potential Radiopharmaceutical for Imaging Bacterial Infection in the Lung.

Li J, Zheng H, Fodah R, Warawa JM, Ng CK.

J Nucl Med. 2018 Jan;59(1):134-139. doi: 10.2967/jnumed.117.195420. Epub 2017 Aug 28.

3.

Attenuation of a select agent-excluded Burkholderia pseudomallei capsule mutant in hamsters.

Gutierrez MG, Warawa JM.

Acta Trop. 2016 May;157:68-72. doi: 10.1016/j.actatropica.2015.12.006. Epub 2016 Feb 1.

PMID:
26836271
4.

Comprehensive identification of virulence factors required for respiratory melioidosis using Tn-seq mutagenesis.

Gutierrez MG, Yoder-Himes DR, Warawa JM.

Front Cell Infect Microbiol. 2015 Nov 4;5:78. doi: 10.3389/fcimb.2015.00078. eCollection 2015.

5.

Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing.

Lawrenz MB, Biller AE, Cramer DE, Kraenzle JL, Sotsky JB, Vanover CD, Yoder-Himes DR, Pollard A, Warawa JM.

Pathog Dis. 2015 Jul;73(5). pii: ftv025. doi: 10.1093/femspd/ftv025. Epub 2015 Apr 9.

6.

Type 3 secretion system cluster 3 is a critical virulence determinant for lung-specific melioidosis.

Gutierrez MG, Pfeffer TL, Warawa JM.

PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3441. doi: 10.1371/journal.pntd.0003441. eCollection 2015 Jan.

7.

Abnormal epithelial structure and chronic lung inflammation after repair of chlorine-induced airway injury.

Mo Y, Chen J, Humphrey DM Jr, Fodah RA, Warawa JM, Hoyle GW.

Am J Physiol Lung Cell Mol Physiol. 2015 Jan 15;308(2):L168-78. doi: 10.1152/ajplung.00226.2014. Epub 2014 Nov 14.

8.

Correlation of Klebsiella pneumoniae comparative genetic analyses with virulence profiles in a murine respiratory disease model.

Fodah RA, Scott JB, Tam HH, Yan P, Pfeffer TL, Bundschuh R, Warawa JM.

PLoS One. 2014 Sep 9;9(9):e107394. doi: 10.1371/journal.pone.0107394. eCollection 2014.

9.

Bioluminescent imaging of bacteria during mouse infection.

Warawa JM, Lawrenz MB.

Methods Mol Biol. 2014;1098:169-81. doi: 10.1007/978-1-62703-718-1_14.

PMID:
24166377
10.

Bioluminescent diagnostic imaging to characterize altered respiratory tract colonization by the burkholderia pseudomallei capsule mutant.

Warawa JM, Long D, Rosenke R, Gardner D, Gherardini FC.

Front Microbiol. 2011 Jun 16;2:133. doi: 10.3389/fmicb.2011.00133. eCollection 2011.

11.

Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens.

Ireland R, Olivares-Zavaleta N, Warawa JM, Gherardini FC, Jarrett C, Hinnebusch BJ, Belisle JT, Fairman J, Bosio CM.

PLoS Pathog. 2010 May 27;6(5):e1000921. doi: 10.1371/journal.ppat.1000921.

12.

Evaluation of surrogate animal models of melioidosis.

Warawa JM.

Front Microbiol. 2010 Dec 29;1:141. doi: 10.3389/fmicb.2010.00141. eCollection 2010.

13.

Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.

Warawa JM, Long D, Rosenke R, Gardner D, Gherardini FC.

Infect Immun. 2009 Dec;77(12):5252-61. doi: 10.1128/IAI.00824-09. Epub 2009 Sep 14.

14.

Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.

Burtnick MN, Brett PJ, Nair V, Warawa JM, Woods DE, Gherardini FC.

Infect Immun. 2008 Jul;76(7):2991-3000. doi: 10.1128/IAI.00263-08. Epub 2008 Apr 28.

Supplemental Content

Loading ...
Support Center